Agios Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Agios Pharma (AGIO) PT Lowered to $96 at H.C. Wainwright
February 24, 2022 12:27 PM ESTH.C. Wainwright analyst Michael King lowered the price target on Agios Pharma (NASDAQ: AGIO) to $96.00 (from $98.00) while maintaining a Buy rating.
... MoreAgios Pharma (AGIO) Misses Q4 EPS by 7c
February 24, 2022 7:04 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.74), $0.07 worse than the analyst estimate of ($1.67).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More


